Accretion Pharmaceuticals Limited (NSE:ACCPL)
India · Delayed Price · Currency is INR 66.30
+2.85 (4.49%)
At close: Mar 25, 2026
Accretion Pharmaceuticals Market Cap
Accretion Pharmaceuticals has a market cap or net worth of 736.44 million as of March 27, 2026.
Market Cap
736.44M
Enterprise Value
813.43M
Revenue
826.43M
Ranking
n/a
PE Ratio
6.74
Stock Price
66.30
Market Cap Chart
Since May 21, 2025, Accretion Pharmaceuticals's market cap has decreased from 922.07M to 736.44M, a decrease of -20.13%. That is a compound annual growth rate of -23.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 736.44M | -24.59% |
| Dec 31, 2025 | 976.54M | 5.91% |
| May 21, 2025 | 922.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bal Pharma | 1.07B |
| Lactose (India) | 1.06B |
| Mercury Laboratories | 1.03B |
| Concord Drugs | 943.33M |
| Makers Laboratories | 868.83M |
| Source Natural Foods and Herbal Supplements | 691.33M |
| Godavari Drugs | 658.09M |
| Amwill Health Care | 640.92M |